Tengion, Inc. (TNGNQ)

OTCMKTS · Delayed Price · Currency is USD
0.0001
+0.0001 (900.00%)
Sep 25, 2025, 8:00 PM EDT
900.00%
Market Cap40.00
Revenue (ttm)n/a
Net Income (ttm)-64.43M
Shares Out40.21M
EPS (ttm)-3.89
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume270,284
Average Volume13,597
Open0.0001
Previous Closen/a
Day's Range0.0001 - 0.0001
52-Week Rangen/a
Beta44.18
RSI2.98
Earnings Daten/a

About Tengion

Tengion, Inc. operates as a regenerative medicine company. The company focuses on discovering, developing, manufacturing, and commercializing a range of neo-organs or products composed of living cells with or without synthetic or natural materials that are implanted or injected into the body to engraft into, regenerate, or replace a damaged tissue or organ. Its product portfolio includes Neo-Kidney Augment to prevent or delay dialysis by increasing renal function in patients with advanced chronic kidney disease; and Neo-Urinary Conduit, which i... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2003
Employees 26
Stock Exchange OTCMKTS
Ticker Symbol TNGNQ
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.